-
A novel HGF/SF Receptor (MET) agonist transiently delays the disease progression in an amyotrophic lateral sclerosis mouse model by promoting neuronal survival and dampening the immune Dysregulation
Researchers studying metabolic dysfunction in adipose tissue have identified NNMT as one of the most consistently upregulated enzymes in obese white fat, making it a high-confidence therapeutic target for metabolic intervention
Key effects include: Delivers bioavailable copper to activate critical copper-dependent enzymes Stimulates collagen, elastin, and glycosaminoglycan production, helping skin, tendons, and connective tissues regenerate Accelerates wound healing and supports remodeling of old or fibrotic tissue Regulates matrix metalloproteinases (MMPs) to balance tissue breakdown and rebuilding Reduces inflammation by lowering cytokines such as TNF-, IL-6, and TGF- Provides antioxidant protection by boosting copper-dependent enzymes Supports hair follicle health and dermal papilla cell activity Influences gene expression related to repair, regeneration, and cell protection Improves tissue resilience in skin, muscle, and joint structures May support cognitive and neural protection through antioxidant and anti-inflammatory mechanisms Key Research Areas and Potential Benefits 1
This means Canadian physicians cannot prescribe BPC-157, and it cannot be sold as a treatment for any medical condition
